ROBERT BELSER, MD
Specialist in LANCASTER, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ROBERT BELSER, MD filed 1,459 Medicare Part D claims in 2023 as a Specialist in LANCASTER, Pennsylvania, prescribing 98% generic.
- 1K
- Part D claims, 2023
- 98%
- generic prescribing
- $138.3
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ROBERT BELSER, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
1,459 Top 20% higher than 80% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
What does the federal data show about ROBERT BELSER, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Pennsylvania
How Specialist compares to other specialties among Pennsylvania providers
Specialist share within Pennsylvania
Specialist is one of the more visible NUCC categories in Pennsylvania
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Specialist (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Specialist ABMS/AOA estimate
Est. board-certified rate (Specialist) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Specialist US NPIs
Specialty board-certified rate — Specialist estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ROBERT BELSER, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 2185 OREGON PIKE, LANCASTER, PA, 17601, with a listed phone of (717) 394-4342. NPI 1821055104 was issued on 04/28/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BELSER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 1,459 prescription claims written by this provider, covering 465 Medicare beneficiaries and totaling roughly $29K in drug spend, split 2% brand-name and 98% generic by claim count, with an opioid prescribing rate of 2.3%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1821055104 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 04/28/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ROBERT BELSER, MD's current license status, disciplinary history, and board certifications with the Pennsylvania State Board of Medicine in Pennsylvania before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where ROBERT BELSER, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT BELSER, MD. Source: openpaymentsdata.cms.gov.
Total received
$138
Largest payer
Optinose US, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to ROBERT BELSER, MD. To verify ROBERT BELSER, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Generic-heavy
2% brand-name claims vs 98% generic, on 1,459 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,084
- Total Day Supply
- 53,517
- Brand vs Generic
- 2% brand / 98% generic
- Brand Drug Cost
- $3K
- Generic Drug Cost
- $25K
- Opioid Claims
- 33 (2.3% rate)
- Antibiotic Claims
- 328
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 58% female / 42% male
- Age Distribution
- <65: 24, 65-74: 203, 75-84: 187, 85+: 51
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ROBERT BELSER, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Omeprazole
Omeprazole
256 claims
- Fluticasone Propio…
Fluticasone Propionate
230 claims
- Famotidine
Famotidine
141 claims
- Cefdinir
Cefdinir
110 claims
- Amoxicillin-Clavul… 85
Amoxicillin-Clavulanate Potass
85 claims
- Pantoprazole Sodium 84
Pantoprazole Sodium
84 claims
- Prednisone 60
Prednisone
60 claims
- Hydrochlorothiazide 53
Hydrochlorothiazide
53 claims
| Drug | Claims |
|---|---|
| Omeprazole | 256 |
| Fluticasone Propionate | 230 |
| Famotidine | 141 |
| Cefdinir | 110 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 85 |
| Pantoprazole Sodium | 84 |
| Prednisone | 60 |
| Hydrochlorothiazide | 53 |
| Montelukast Sodium | 46 |
| Doxycycline Hyclate | 39 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How ROBERT BELSER, MD fits within the Specialist landscape nationally.
ROBERT BELSER, MD's 1,459 claims are below the specialty average of 1,474.
Nearby Specialist Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as BELSER.
Compare Specialist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Pennsylvania
Frequently Asked Questions
What is ROBERT BELSER, MD's specialty? ▼
How much does ROBERT BELSER, MD prescribe under Medicare Part D? ▼
Where is ROBERT BELSER, MD located? ▼
What is ROBERT BELSER, MD's NPI number? ▼
Does ROBERT BELSER, MD prescribe more brand-name or generic drugs? ▼
Does ROBERT BELSER, MD prescribe opioids? ▼
How many Specialist providers are there in the US? ▼
What drugs does ROBERT BELSER, MD prescribe most often? ▼
Does ROBERT BELSER, MD accept Medicare? ▼
How can I verify ROBERT BELSER, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology